共 59 条
[1]
Rovin BH(2021)KDIGO 2021 clinical practice guideline for the Management of Glomerular Diseases [J] Kidney Int 100 S1-S276
[2]
Adler SG(2009)A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study [J] Nephrol Dial Transplant 24 3068-3074
[3]
Barratt J(2019)Prediction and risk stratification of kidney outcomes in IgA nephropathy [J] Am J Kidney Dis 74 300-309
[4]
Goto M(2012)Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population [J] Nephrol Dial Transplant 27 1479-1485
[5]
Wakai K(2011)Predicting the risk for Dialysis or death in IgA nephropathy [J] J Am Soc Nephrol 22 752-761
[6]
Kawamura T(2009)The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification [J] Kidney Int 76 534-545
[7]
Chen T(2017)A multicenter study of the predictive value of crescents in IgA nephropathy[J] J Am Soc Nephrol 28 691-701
[8]
Li X(2016)Outcomes of IgA nephropathy with segmental glomerular necrosis but without crescent formation[J] Am J Nephrol 43 341-347
[9]
Li Y(2012)A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients[J] American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 60 812-820
[10]
Le W(2016)Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy[J] Hum Pathol 49 135-144